BLUE BELL, Pa., April 29, 2011 /PRNewswire/ — Inovio
Pharmaceuticals, Inc. (NYSE Amex:
INO), a leader in the development of therapeutic and preventive
vaccines against cancers and infectious diseases, announced today
that the company will make presentations at three investor
conferences:
JMP Securities Research Conference
San Francisco, CA, May 9-11, 2011
The Ritz-Carlton, San Francisco
Inovio Presentation
Dr. J. Joseph Kim, Ph.D., President & CEO
May 9, 2011
10:30 AM
http://www.jmpg.com/wp-content/files_mf/jmp_may2011_invite_v3.pdf
MDB Bright Lights Conference
New York, NY, May 10-11, 2011
Le Parker Meridien Hotel
Inovio Presentation
Thomas Kim, VP, IP and Associate General Counsel
May 11, 2011
10:00 AM
Bright Lights is an investment conference focused on publicly
traded companies with disruptive and market changing intellectual
property (IP). Inovio was selected from MDB’s 2011 group of “Best
and Brightest” small-cap companies; a group that is advancing some
of today’s most innovative and market-leading IP. Inovio is
one of the 40 public companies ranking in the 90th percentile for
its respective technology leadership from more than 1,500 small-cap
companies with granted U.S. patents, as rated by PatentVest, MDB’s
proprietary IP business intelligence platform.
http://www.mdb.com/2011-bright-lights-conference.html
Noble Financial Investor Conference
Hollywood, FL, May 16-17, 2011
Hard Rock Hotel
Inovio Presentation
Dr. J. Joseph Kim, Ph.D., President & CEO
May 16, 2011
2:00 PM
‘/>”/>
